Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer

BACKGROUND: Advances in cancer immunotherapy have generated encouraging results in multiple malignancies refractory to standard chemotherapies. As the use of immune checkpoint inhibitors (ICI) proliferates, the incidence of autoimmune side effects associated with these agents, termed immune related...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Godwin, James Luke, Jaggi, Shuchie, Sirisena, Imali, Sharda, Pankaj, Rao, Ajay D., Mehra, Ranee, Veloski, Colleen
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5433051/
https://ncbi.nlm.nih.gov/pubmed/28515940
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-017-0245-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars